This site requires Adobe Flash Player 8.0 and JavaScript enabled

The Advisory Panel

“Individual wellness drive corporate performance and contributes to corporate social responsibility.”

Professor Adam Carey BSc MB BChir MA MRCOG

Corperformance Consulting Ltd

Dr. John Costello MD, FRCP, FRCPI

Dr. Costello is recognised internationally for his work in Respiratory Medicine. His current strategic advisory and clinical practice positions include Honorary Consultant Physician, King’s College Hospital, Visiting Fellow King’s College London and Clinical Director and Consultant Physician Cromwell Hospital. Dr. Costello’s work has generated approximately £4m of research funds from Family and Commercial investors.

In addition Dr. Costello is Chairman of Capital Hospitals £1.2bn St. Bartholomew’s Hospitals PFI funded rebuild and servicing project, the largest such PFI project worldwide. As Chairman of Skanska/Innisfree he also leads the £480m project bid for the re-build of Southmeads Hospital, Bristol. Dr. Costello is a Non-executive director of Medicsight plc, a software company developing novel programs for radiological interpretation of lung cancer, colon cancer and coronary heart disease.

Previous clinical, academic and business roles include Chairmanship, Clinical Director, Trust Board member, Policy Advisor, Professor, Expert Advisor, Examiner and Consultant Physician. As an author of multiple books related to Asthma and lung infections and with a substantial series of conference presentations, refereed journal papers and software publications, Dr. Costello is recognised as a leading international adviser and practitioner in his field, having also been featured in Who’s Who.

Mr Michael Waller-Bridge

Mr Michael Waller-Bridge MSI

Michael’s experience in venture capital was won in the vanguard of the electronic trading revolution, first with joint venture work in the financial services industry at the London Stock Exchange, next with member markets of the Federation of European Stock Exchanges, then as Co-founder & CEO of the Tradepoint Stock Exchange, the groundbreaking electronic market which since became a unit of the Swiss Stock Exchange, and subsequently with other developing entrepreneurial businesses. Originally trained as a physicist, Michael Waller-Bridge was recruited to the London Stock Exchange during the “Big Bang” transitions of the 1980’s, joining a team focusing on the market’s development of future electronic and trading services. Before then Michael had been instrumental, together with colleagues from Imperial College, London University, in a venture which developed opto-digital holographic recording techniques for medical imaging applications. Michael is a Member of the Securities and Investment Institute and a Member of the peer-appointed World Technology Network, where he also serves as a Nominator in the annual WTN Awards process. Over the past two years he has also served on the investment committee and as an investment manager to a pre-IPO fund based in London which invests in expansion phased companies with no sector bias.

Ms Teresa Hale

Teresa Hale is regarded as one of the World's leading "health visionaries". She has played a major role in growth of Complementary Medicine over the last 25 years. Teresa is a firm believer in pro-active healthcare.

The Times: “Teresa Hale has arguably had the most influence on the development of Complementary medicine in the UK”.

The Evening Standard: “Teresa Hale is the biggest name in Complementary Medicine in the UK”.

Good Housekeeping: “Teresa Hale was voted one of the 100 most influential women in the country”.

Teresa Hale founded the Hale Clinic, London in 1987. HRH The Prince of Wales opened the Clinic officially in 1988 and Teresa has been at the helm as Managing Director ever since. The Hale Clinic opened in London's elegant Park Crescent. Twenty five purpose built consulting rooms, a library/bookshop and a dispensary are housed in the stately Nash Terrace building. Over 40 different treatments are available from 75 practitioners who are based at the Clinic. The Clinic treats 2,500 patients every month. Chiropractors, healers, reflexologists, masseurs’ work side by side treating whole range of conditions. Many of the therapists are multi-disciplinary and a number are qualified medical doctors. Teresa believes that Complementary Medicine should not be seen as an alternative to orthodox medicine - rather neither system has the whole answer to every medical problem. It is the aim of the Hale Clinic to attract the highest calibre practitioners to further the acceptance of complementary Medicine throughout the community and to offer the public a different approach to health care. Teresa has had extensive experience in managing people involved in Well Being and getting their innovative ideas accepted as part of mainstream thought. Teresa has appeared many times on Television and other media, including News at Ten and CNN and a documentary on The Hale Clinic on the Discovery Channel. The Hale Clinic has also produced three other documentaries on Complementary Medicine which were shown on Discovery Channel. Teresa Hale has lectured in the USA, UK, EU and UAE. Teresa has been Patron for two years of the first Exhibition and Conference on Complementary Medicine and Well Being in UAE. Teresa has published two books. The Hale Clinic Guide to Good Health, and Breathing Free. Her third book titled “Regeneration” will be published later this year, accompanied by another 6 books in the Hale Book Series beginning publication in 2008. The Hale Clinic has also carried out two research projects in Complementary Medicine at Hammersmith Hospital and Imperial College, London University.

Dr. Marilyn Glenville

Dr. Marilyn Glenville BEd (Hons), MA, PhD (Camb)

Dr. Marilyn Glenville PhD is a registered member of the Nutrition Society, a Fellow of The Royal Society of Medicine, psychologist, author and broadcaster who obtained her doctorate from Cambridge University.

Dr. Glenville has studied and practised nutrition for over 25 years, both in the UK and in the USA, focusing on the natural approach to female hormone problems. Today she is recognised as the UK’s leading nutritionist specialising in women’s health.

She is the President of the Food and Health Forum at the Royal Society of Medicine and is a patron of the Daisy Network, a charity for premature menopause. Dr. Glenville was also formerly an observer on the Food Standards Agency’s Expert Group on the safety of vitamins and minerals. Dr. Glenville has had many papers published in scientific journals, frequently advises health professionals and has lectured at academic conferences held at The Medical Society, The Royal College of Physicians and The Royal College of Surgeons.

Dr. Glenville was invited to give a presentation in the House of Lords to The Scientific and Technology committee, on behalf of The Nutritional Therapy Council (NTC), on the standards of nutritional training in the UK and the benefits of nutritional therapy to the general public.

In 2005, Dr. Glenville was also invited to give a presentation at The Royal Society of Medicine as part of the celebrations to mark the RSM’s bicentennial year in conjunction with the Prince of Wales’ Foundation for Integrated Health.

With her special interest in the female hormone cycle, Dr.Glenville frequently works with women who suffer menstrual problems such as heavy periods, painful periods, PMS, fibroids, PCOS and endometriosis, and who wish to work on a nutritional approach to these problems. Dr.Glenville also helps couples who are having difficulty conceiving or having recurrent miscarriages.

Dr. Glenville is also a popular international speaker. As a respected author on women's healthcare she gives regular talks on radio and has often appeared on television and in the press. Dr.Glenville is President Elect on the Forum for Food and Health at the Royal Society of Medicine, is an Expert observer for the FSA (The Food Standards Agency) for safety of vitamins and minerals in the UK, a Chartered Psychologist, a Fellow of the Royal Society of Medicine, a Fellow of the Royal Society of Arts, a Former Chair of the Nutritional Therapy Council, a Former Chair of the British Association of Nutritional Therapists, a Former Chair of Foresight - the Association for Preconception Care and Infertility, a Member of the British Menopause Society, a Member of the National Osteoporosis Society and a Member of the British Fertility Society

Dr. Glenville is the author of 8 internationally bestselling books (including the international best seller ‘The New Natural Alternatives to HRT’ published in February 2003 and which has been reprinted many times in the UK and is sold in over 20 countries around the world) many of which have become the standard reference books for practitioners and have sold over 500,000 copies worldwide.

Dr. Linda Friedland

Linda Friedland is a medical doctor, best-selling author, recognized international conference speaker, women’s & executive health consultant and radio & television personality. Her television career includes several years as the medical expert for the SABC 3(3 Talk) and an anchor for a weekly medical show on TV 2. Her first book was published in South Africa in 2005 and reached local bestseller sales within 6 months. She is a feature writer for Business day, many health and women’s publications, as well as the ‘Radio doctor’ (a weekly radio show broadcast across the African continent by channel Africa).

In addition to numerous presentations in the US and UK, requests for her as a speaker and corporate consultant have taken her as far a field as Portugal, Italy, Switzerland, Cyprus, Indonesia, Malaysia, Thailand, Japan, the Philippines, India, Turkey, and China in the past year alone. She continues to design and implement numerous health, lifestyle and illness prevention programs for corporations throughout Asia and the UK.

The mother of 5 children, she is listed as one of the 100 Who’s Who of South African women in Woman Today-50 years of South African women newsmakers.

Ms Stephanie French

Stephanie French is a nutrition strategy consultant to the food industry. She is a Registered Nutritionist in the UK and has an MSc in Nutrition from the University of Sheffield as well as an MA in Philosophy and Psychology from the University of Oxford. She has also recently completed some part-time post-graduate research at the Hugh Sinclair Unit of Human Nutrition, University of Reading on the links between diet and sub-clinical health complaints. Stephanie has extensive commercial experience, having run her own sales and marketing consultancy for over 15 years. During this time she has been responsible for introducing numerous consumer goods companies to new international markets as well as providing strategic advice on new business development. Prior to setting up her own consultancy she held business development roles for United Distillers (now Diageo) and Avis Rent-a-Car.

Stephanie’s work now centres on the new product development and marketing of health-enhancing foods together with an ever growing emphasis on longer term strategic trend forecasting and planning in this sector (www.nutritiondirections.co.uk). In this role she is increasingly in demand for her experience in forecasting future market developments as well as providing intelligence on market trends for Europe in particular.

Her clients include several leading European food manufacturers and retailers and recent projects have covered areas such as the development of nutrition credentials and a communication plan for a new snacking concept, a 3 year strategic plan for the nutritional enrichment of beverages and a plan for the re-positioning of a range of ambient meal solutions on a health platform.

Professor Adam Carey

Professor Adam Carey is a doctor, nutritionist and leading commentator on all areas of sports nutrition and human performance.

After qualifying from Oxford University Medical School in 1988, he went on to become an accredited specialist in Obstetrics and Gynaecology with sub-specialist interests in endocrinology and nutrition.

Adam left the NHS in 1998 to actively develop the use of nutritional and lifestyle strategies to improve human performance and reduce the risk of disease through proactive preventative medical management.

Adam was Head of Nutrition for the England Rugby Football Union from 1999 to 2006 which included their World Cup win, and performed a similar role for the England Cricket squad in 2005, prior to their success reclaiming the Ashes. His new role is consultant to the British Olympic Association in the preparation for the 2012 Olympic Games.

Adam is also a director of Corperformance Consulting, a company that provides nutritional solutions and coaching to corporate clients that improves individual wellbeing, reduces sickness and absence and impacts positively to the bottom line of the business. Their clients include BP and Ineos.

In addition, Adam is a visiting Professor in Nutrition at Leeds Metropolitan University, a non-executive director of Yorkshire Culture; he is Chairman of the European Specialist Sports Nutrition Alliance, writes extensively for consumer magazines and has been published widely. He was the nutritional expert and co-presenter for programmes including ITV’s ‘Celebrity Fit Club’, ‘Truth about…’ series and Sky One’s ‘Change the Day You Die’.

Mr Matt Christensen

Matt Christensen has served as Executive Director of Eurosif since 2002. Eurosif addresses sustainability issues through financial markets on behalf of its Member Affiliates which include leading financial service institutions that together represent assets totalling over euro 600bn. Recent activities of Eurosif include its EU SRI Market Study, Venture Capital and Sustainability Report and successful submissions to the EU asking for improved transparency on environmental social / governance issues by companies and funds. Matt is a frequent speaker at international events on sustainable investment matters that range from the publicly listed markets to private equity. He is also a member of the European Commission Coordination Committee to explore the evolution of sustainability in the EU and was recently an expert for an EC workshop dedicated to improving the financing of high growth, eco-efficiency enterprises in the 27 Member States.

Matt was formerly a European Director at The Motley Fool, a leading publisher of information on personal finance and investing. Prior to that, he advised FTSE 100 clients as a strategy consultant with Braxton Associates based in London and Paris. He is a Non-Executive Director to various investment funds and holds masters degrees from Wharton (MBA – Entrepreneurial Management) and the University of Pennsylvania (MA – International Political Economy).

Mr Bryan Foss

Bryan is an independent non-executive director (NED) and board level advisor. He is currently a Non-Executive Director at a major government department, also an Audit Committee member and Chair of Client Standards (for accuracy, complaints and appeals). In addition he has been appointed as external adviser to the CEO and programme board of a 3 year £250m Operational Improvement Programme (OIP) project, which includes substantial staff and process change, also contact centre and IT systems improvements.

Bryan also provides retained board level advice to a small number of businesses creating innovative services for consumers, these are often technology based and mainly deployed by large scale consumer organisations. Areas of operation include consumer research, consumer management, partner management etc – in particular helping business boards to understand how the consumer views their core purpose in terms of life style and wellbeing and the transition efforts required to deliver the required customer experience and benefits.

Bryan was previously an IBM worldwide banking board member (board turnover in excess of $45bn pa) and executive working with very large and complex consumer-led business transformation projects especially in US, European, Chinese and Asean companies, where unique and complex sales, service and retention challenges have arisen.

Bryan has co-authored six Kogan Page business books with Professor Merlin Stone and others and is recognised globally for his work on consumer insight, consumer experience management and board effectiveness. He continues to write regularly for online publications.

Bryan’s post MBA (City University, London) qualifications include Fellow of the Chartered Institute of Marketing (FCIM), Diploma in Marketing (DipM), Member of the Institute of Direct Marketing (MIDM), Fellow of the British Computer Society (FBCS), Chartered Engineer (C Eng) and Chartered Information & Technology Professional (CITP). In addition Bryan holds the Certified Diploma in Accounting and Finance (CDipAF) and is a Freeman of the City of London and Liveryman of the Worshipful Company of Marketers.

Mr James Kraft

James was born and raised in Seattle, Washington but has spent the last 20 years working in the consumer retail, media, healthcare and technology industries in Europe. To date he has co-founded and served as Managing Director of five companies in Germany and the UK, building each business from start-up to profitability. James' most recent company, New Medical Ltd. provides evidence-based, preventative health screening services to patients through GPs and major health retailers. New Medical Limited delivers evidence based screening services to patients either through their GPs or direct to the consumer. Its focus is on technology supported, preventative medicine that is currently underserved by the NHS and private providers. To date, New Medical has scanned more than 15,000 patients on a self-pay basis for life threating and debilitating conditions such as Abdominal Aortic Aneurysm (AAA) and Osteoporosis. By utilising existing health facilities such as GP clinics and high street retailers, New Medical is able to keep the costs of its tests affordable to the majority of patients while offering a local and convenient solution.

New Medical's screening programmes have saved hundreds of lives and provided its patients with the peace of mind that comes from a proactive approach to health prevention. James holds a BA Economics from Stanford University.

Mr Ewan Reid Matt Christensen has served as Executive Director of Eurosif since 2002. Eurosif addresses sustainability issues through financial markets on behalf of its Member Affiliates which include leading financial service institutions that together represent assets totalling over euro 600bn. Recent activities of Eurosif include its EU SRI Market Study, Venture Capital and Sustainability Report and successful submissions to the EU asking for improved transparency on environmental social / governance issues by companies and funds. Matt is a frequent speaker at international events on sustainable investment matters that range from the publicly listed markets to private equity. He is also a member of the European Commission Coordination Committee to explore the evolution of sustainability in the EU and was recently an expert for an EC workshop dedicated to improving the financing of high growth, eco-efficiency enterprises in the 27 Member States. Matt was formerly a European Director at The Motley Fool, a leading publisher of information on personal finance and investing. Prior to that, he advised FTSE 100 clients as a strategy consultant with Braxton Associates based in London and Paris. He is a Non-Executive Director to various investment funds and holds masters degrees from Wharton (MBA – Entrepreneurial Management) and the University of Pennsylvania (MA – International Political Economy). Matt Christensen Matt Christensen has served as Executive Director of Eurosif since 2002. Eurosif addresses sustainability issues through financial markets on behalf of its Member Affiliates which include leading financial service institutions that together represent assets totalling over euro 600bn. Recent activities of Eurosif include its EU SRI Market Study, Venture Capital and Sustainability Report and successful submissions to the EU asking for improved transparency on environmental social / governance issues by companies and funds. Matt is a frequent speaker at international events on sustainable investment matters that range from the publicly listed markets to private equity. He is also a member of the European Commission Coordination Committee to explore the evolution of sustainability in the EU and was recently an expert for an EC workshop dedicated to improving the financing of high growth, eco-efficiency enterprises in the 27 Member States. Matt was formerly a European Director at The Motley Fool, a leading publisher of information on personal finance and investing. Prior to that, he advised FTSE 100 clients as a strategy consultant with Braxton Associates based in London and Paris. He is a Non-Executive Director to various investment funds and holds masters degrees from Wharton (MBA – Entrepreneurial Management) and the University of Pennsylvania (MA – International Political Economy). Professor Adam Carey

Mr Ewan Reid

Ewan (52) is a Chartered Mechanical Engineer and Member of the Institution of Mechanical Engineers.

Ewan has wide-ranging experience in mechanical design engineering across a spectrum of applications from automated materials handling, food processing equipment, oil well drilling equipment, oil and gas pipeline connection systems, and polymer and glass reinforced plastic products. In these connections he has worked with digital electronics and microcontroller systems since 1979. His extensive experience with leading companies in their field included appointments with Unilever Research Laboratories (3 years), Hunting Oilfield Services (10 years) and Lansing Bagnall Ltd (5 years) with responsibilities in research, design and general management. Ewan also gained direct experience in the wellness sector through contract work as a supplier to Balmoral Wellbeing.

Ewan set up Progreen Ltd in March 2003 in partnership with his son, a Computer Science and Artificial Intelligence specialist, to design customised process control systems and provide general design consultancy services. Products to date have included a custom design pipe connection machine, waste water treatment control and monitoring equipment and leisure products. Ewan was educated at Aberdeen Grammar School and is a graduate of Robert Gordon's University, Scotland (HND Mech Eng) and Gwent College of Higher Education (CEng).

Mr Laurie Rostron

Laurie Rostron

Laurie Rostron has considerable knowledge and experience of the healthcare industry gained from nearly 30 years working for multinational healthcare companies and over 23 years in the venture capital industry as an investor, an Adviser and a Non Executive Chairman/Director.

For 13 years he was a General Partner of Alta Berkeley Associates specialising in start up and early stage advanced technology investments in the healthcare industry on a pan European basis. Since his retirement from Alta Berkeley 10 years ago, he has been an Independent Venture Capital Adviser. During the past 23 years he has been a Non Executive Director of over 20 different healthcare companies with a wide range of leading edge technologies including drug discovery, biotechnology, devices, implants, medical equipment and diagnostics, all operating in high growth international markets.

He was previously the Managing Director of Viggo International, an intravenous products company within the BOC Healthcare Group, the General Manager of a division of G.D. Searle & Co and the Marketing Manager of the Hospital Division of Johnson & Johnson.

He has extensive experience of nurturing start up companies, organising and raising new finance, advising on management development, organisation and recruitment, strategic planning and strategic alliances and the IPO process.

He is 73 years old and he currently has one Non Executive Chairmanship, two Non Executive Directorships and is an Adviser to two Venture Capital Funds and an early stage orthopaedic company.

Professor James Scott FRS

Dr. Scott is currently Professor of Medicine and Cardiovascular Medicine at Imperial College London. He was previously Chair of Medicine and Chief of Service, Chief of Cardiology and Head of Molecular Medicine at The Royal Postgraduate Medical School, Hammersmith Hospital. He was founder and first Head of The Institute of Genetics and Genomics and founder of the Bioinformatics Centre at Imperial College London. He is a member of the European Molecular Biology Organization (EMBO), and was EMBO fellow at the University of California, San Francisco. He has received prizes from The Royal College of Physicians London, Glaxo Smith Kline, and Bristol Myers Squibb. He was elected Fellow of the Royal Society in 1997. He is distinguished for the discovery of RNA editing and common genetic variation causing dyslipidaemia, heart disease and obesity. Current interests include genome wide association and systems biology studies in cardiovascular and metabolic disease, and preventive cardiology. He has a particular interest in health and wellbeing into longevity, through disease prevention. He received his medical degree at London University in 1971. Dr. Scott is the author of many seminal publications.

Mr Ben Clarke

Ben has a very strong track record of delivering top tier performance for multi-national food companies over the last 18 years.

Having been sponsored through a business degree by United Biscuits,

Ben joined UB as a marketing graduate in 1989. Following 4 years of progression in various marketing roles covering new product development and brand building he joined Kraft Foods UK as a Senior Brand Manager. He progressed to Marketing Manager for Kraft’s flagship coffee business before moving to Kraft’s head office in Chicago as Manager of Strategy for two of Kraft Foods North America’s biggest divisions – Meals and Enhancers.

Ben returned to the UK in 1999 as Category Director for Coffee and Confectionery assuming strategic, operational and financial responsibility for brands such as Kenco, Maxwell House, Terry’s of York, Toblerone and Suchard. Having delivered three consecutive years of strong market share, revenue and income growth he transferred to Melbourne as Area Director and Vice President for Kraft Foods Australia, New Zealand and Asia Pacific Exports. Under Ben’s leadership in Australia Kraft delivered record revenue and income performances.

Ben returned to the UK in 2006 as Area Director and Vice President for Kraft Foods UK and Ireland where he again delivered strong top and bottom line performances while growing share in 4 of 5 categories. In March 2008 Ben left Kraft as he did not wish to relocate to Kraft Europe’s new headquarters in Zurich.

As well as consistently delivering strong business results over a long period Ben also championed Kraft’s CSR agenda focussing on combating obesity by leading an integrated programme of enhanced food labelling, enhanced product nutrition through reformulation and by introducing self-regulated marketing restrictions. Additionally he drove Kraft’s “Health 4 Schools” program in Gloucestershire and the increasing use of ethically sourced commodities – notably coffee.

Ben was recognised for these contributions in 2007 when HRH The Prince of Wales appointed him as an Ambassador for Business in the Community.

Note: With net revenues, in 2006, of $34 billion Kraft Foods, Inc (NYSE: KFT) is one of the world's largest food and beverage companies. For over 100 years, Kraft has offered consumers delicious and wholesome foods that fit the way they live. Kraft markets a broad portfolio of iconic brands in 155 countries, including seven brands with revenue of more than $1 billion, such as Kraft cheeses, dinners and dressings, Oscar Mayer meats, Philadelphia cream cheese, Post cereals, Nabisco cookies and crackers, Jacobs coffees and Milka chocolates. Kraft became a fully independent company on March 30, 2007, and is listed in the Standard & Poor's 100 and 500 indices. The company is a member of the Dow Jones Sustainability Index and the Ethical Sustainability Index.

Mr Zef Eisenberg

Zef Eisenberg is considered to be one of the leading experts on physique nutrition in the UK. He personally led the development and awareness of sports nutrition in the UK and its application in helping people transform their physique and increase their sporting performance. He is the author of several best selling books on the subject of training, performance nutrition, bodybuilding and owns leading websites on these topics.

With two decades of personal and financial involvement in the industry, Zef remains at the cutting edge of sports nutrition development and legislation. He was responsible for many industry firsts, including Creatine, HMB, Whey Protein, Glutamine and numerous other performance ingredients that are viewed today as industry standard products within the health food, supplement and sports nutrition world.

Zef’s advisos UK Sport and other organisations in helping address the global ‘doping problem’ in the sports arena. He pioneered the development of the world’s first independent drug screening tests for sports nutrition products and supplements to prove their safety. Zef has become a sought-after advisor in policy, having provided evidence at the UK Government select HIT committee for the upcoming Olympics 2012.

He leads the HFMA (health food manufactures association) sports nutrition working group and is Vice-Chair of ESSNA (European specialist sports nutrition alliance). Zef is closely involved in these organisations and is dedicated to challenging negative food legislation from the EC. Since relocating to Guernsey in 2005, he has advised both specialist local companies and the States Government as to strategy in this area.

Since Maximuscle Ltd was founded by Zef in 1995, it has grown organically without any outside investors or bank debt to become Britain’s no.1 brand in just 6 years, with a 21% net profit growth each year. In 2004, Piper Private Equity took a stake for £9.6m, where growth continued with net profits up 53% each year. In Dec 2007, Zef sold a majority share to Darwin Private Equity for £75m, with Zef now sitting as board member and President.

Zef is an active investor in private equity, taking advisor or consultant roles in areas of food, fitness and nutrition for several leading private equity groups.